Company review


GeneTechnology was founded in 2001. Our team was among the first in Russia to develop and introduce high tech molecular-genetic approaches for applied medicine.

In our medical center we help people with coagulopathy, anaemia, genetic hematological disorders, thrombophilia, Hodgkin's lymphoma, non-Hodgkin`s lymphoma, myelodysplasia, myeloproliferative disorders (Ph+ and Ph-) and hemoblastosis.

In our GeneTechnology medical center we have our own laboratory which carries out all necessary clinical, molecular-genetic and cytogenic research. Our approach is based upon our own original developments as well as up-to-date methods of molecular diagnostics (polymerase chain reaction, sequence analysis, standard cytogenetics and fluorescence in situ hybridization) applied in molecular-biological laboratories worldwide and use innovative approaches in full accordance with international standards.

GeneTechnology conducts scientific and practical collaboration with city, federal and private clinic all over Russian Federation.

Company`s main fields:

  •  Development and introduction of up-to-date molecular-genetic approaches into diagnostics and treatment of oncological, hematological, genetic and bleeding disorders;
  • outpatient diagnostics, coagulopathy and hemoblastosis treatment;
  • search of new target genes for diagnostics and monitoring of residual oncological and hematological diseases;
  • development of antitumor vaccines and therapeutic antibodies;
  • clinical research participation;
  • development and production of diagnostic test systems.


Educational programs for doctors and laboratory workers are the main part of our activity.